NCT01045486 is a NA clinical trial of ATP mixed probiotics in Atopic Dermatitis, sponsored by Soonchunhyang University Hospital.

Who is sponsoring NCT01045486?

NCT01045486 is sponsored by Soonchunhyang University Hospital.

What drugs are being tested in NCT01045486?

Interventions in NCT01045486: ATP mixed probiotics, Placebo.

What condition does NCT01045486 study?

NCT01045486 studies Atopic Dermatitis.

Is NCT01045486 still recruiting?

NCT01045486 is currently withdrawn. Last updated 20 July 2011.

Last reviewed 2011-07-20 · How we verify

NCT01045486

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

A Double Blind, Randomized, Placebo-Controlled, Crossover Study to Compare the Effectiveness of Probiotics on Atopic Dermatitis With Cow Milk Allergy in Korean Infants

Withdrawn NA Last updated 20 July 2011

What this trial tests

NA trial testing ATP mixed probiotics in Atopic Dermatitis in 36 participants. Withdrawn.

Timeline

1 January 2010

Primary endpoint
1 August 2010

1 September 2010

Quick facts

Lead sponsor	Soonchunhyang University Hospital
Phase	NA
Status	Withdrawn
Study type	INTERVENTIONAL
Allocation	randomized
Design	crossover
Masking	quadruple
Primary purpose	treatment
Enrollment	36
Start date	1 January 2010
Primary completion	1 August 2010
Estimated completion	1 September 2010

Drugs / interventions tested

ATP mixed probiotics — full drug profile →
Placebo

Conditions studied

Atopic Dermatitis — all drugs for Atopic Dermatitis →

Sponsor

Soonchunhyang University Hospital

Who can join

Adults 6 Months to 2, any sex, with Atopic Dermatitis. Patients with the condition only — healthy volunteers not accepted.

What's being measured

Primary outcomes are the specific endpoints the trial is designed to prove or disprove.

Check SCORAD index for severity of atopic dermatitis, symptom diary, blood cytokine and chemokine (IL-4,IL-6, IL-10, IL-13, total IgE, IFN-γ, TGF-β, TNF-α, and IgG4) after drug administration
Time frame: 6 weeks after patient recruitment

Sponsor's own description

There is not enough evidence to support the use of probiotics for prevention or treatment of AD in children in clinical practice. The purpose of this study is to determine whether probiotics is effective in the treatment of atopic dermatitis with cow milk allergy.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Atopic Dermatitis

Currently open trials in the same condition.

NCT07262983 — Evaluating the Safety and Tolerability of Baricitinib in Patients With Job Syndrome With Lupus-Like Disease and/or Atopi · Phase 1 · recruiting
NCT07445919 — A Clinical Study to Evaluate SM17 for Atopic Dermatitis · Phase 2 · recruiting
NCT07488065 — A Study of SKB575 (HBM7575) Injection in Healthy Participants and Atopic Dermatitis Participants · Phase 1 · recruiting
NCT07467564 — The Impact of Dupilumab Treatment on Anxiety and Depression Symptoms in Patients With Moderate-to-Severe Atopic Dermatit · recruiting
NCT07358156 — A Study to Compare the Pharmacokinetics, Pharmacodynamic, Immunogenicity, and Safety of CKD-706 With US-Dupixent®, and E · Phase 1 · recruiting

Other Soonchunhyang University Hospital trials

Trials by the same sponsor.

NCT07213596 — Virtual Reality Treatment for Trauma Related to COVID-19 Infection · NA · not yet recruiting
NCT06950489 — Tegoprazan and Amoxicillin Dual Therapy · recruiting
NCT06682533 — Tegoprazan- Versus PPI-based H. Pylori Eradication · recruiting
NCT06684860 — RUT vs. Molecular Testing for H. Pylori · recruiting
NCT06369896 — Digital Single-operator Cholangioscopy and Intraductal Ultrasound for Nonicteric Biliary Strictures · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT01045486 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Soonchunhyang University Hospital
Last refreshed: 20 July 2011

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT01045486.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing